Twin Capital Management Inc. acquired a new position in Synopsys, Inc. (NASDAQ:SNPS – Free Report) in the 1st quarter, HoldingsChannel.com reports. The institutional investor acquired 3,529 shares of the semiconductor company’s stock, valued at approximately $1,399,000.
Several other institutional investors and hedge funds also recently made changes to their positions in SNPS. China Universal Asset Management Co. Ltd. lifted its position in shares of Synopsys by 31.8% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 14,810 shares of the semiconductor company’s stock valued at $6,957,000 after acquiring an additional 3,575 shares during the period. SeaTown Holdings Pte. Ltd. boosted its stake in Synopsys by 55.9% during the fourth quarter. SeaTown Holdings Pte. Ltd. now owns 22,300 shares of the semiconductor company’s stock worth $10,475,000 after acquiring an additional 8,000 shares in the last quarter. Norges Bank acquired a new stake in Synopsys in the fourth quarter worth $730,197,000. Douglas Lane & Associates LLC grew its holdings in Synopsys by 5,701.2% in the fourth quarter. Douglas Lane & Associates LLC now owns 48,730 shares of the semiconductor company’s stock worth $22,889,000 after purchasing an additional 47,890 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. increased its stake in Synopsys by 11.3% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 131,369 shares of the semiconductor company’s stock valued at $61,707,000 after purchasing an additional 13,320 shares in the last quarter. Institutional investors own 85.47% of the company’s stock.
Synopsys Stock Down 0.1%
Synopsys stock opened at $425.27 on Thursday. Synopsys, Inc. has a fifty-two week low of $376.18 and a fifty-two week high of $651.73. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.32 and a current ratio of 1.43. The firm’s 50-day simple moving average is $473.71 and its 200 day simple moving average is $459.57. The stock has a market cap of $81.43 billion, a PE ratio of 98.44, a price-to-earnings-growth ratio of 2.50 and a beta of 1.22.
Analysts Set New Price Targets
SNPS has been the topic of several research reports. Morgan Stanley upped their price objective on shares of Synopsys from $480.00 to $525.00 and gave the company an “equal weight” rating in a report on Thursday, May 28th. Rosenblatt Securities boosted their target price on Synopsys from $530.00 to $575.00 and gave the company a “buy” rating in a research report on Tuesday, May 26th. BNP Paribas Exane upped their price target on Synopsys from $425.00 to $450.00 and gave the stock an “underperform” rating in a research note on Thursday, May 28th. Piper Sandler upgraded Synopsys from a “neutral” rating to an “overweight” rating and increased their price target for the stock from $450.00 to $550.00 in a report on Tuesday, June 23rd. Finally, Citigroup raised their price objective on Synopsys from $600.00 to $610.00 and gave the company a “buy” rating in a research note on Thursday, May 28th. One investment analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Synopsys has an average rating of “Moderate Buy” and an average target price of $570.06.
Get Our Latest Research Report on Synopsys
Insider Buying and Selling
In other Synopsys news, CEO Sassine Ghazi sold 14,603 shares of the business’s stock in a transaction on Monday, June 15th. The stock was sold at an average price of $458.96, for a total value of $6,702,192.88. Following the transaction, the chief executive officer owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. The trade was a 16.29% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the company’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $450.02, for a total value of $1,527,367.88. Following the completion of the transaction, the chief financial officer owned 14,358 shares of the company’s stock, valued at $6,461,387.16. This trade represents a 19.12% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.56% of the company’s stock.
Synopsys Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Further Reading
- Five stocks we like better than Synopsys
- Why Johnson & Johnson’s Earnings Dip Looks Like a Buying Opportunity
- CPI Comes In Cool: Why It Could Revive These 3 Rate-Sensitive Stocks
- Why ASML’s AI Monopoly Is Still Getting Stronger
- Apple’s AI Toll Booth Thesis Faces Its Biggest Test Yet Before Earnings
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
